tiprankstipranks
Trending News
More News >
Nosa Plugs AB (SE:NOSA)
:NOSA
Sweden Market

Nosa Plugs AB (NOSA) AI Stock Analysis

Compare
0 Followers

Top Page

SE:NOSA

Nosa Plugs AB

(NOSA)

Select Model
Select Model
Select Model
Neutral 48 (OpenAI - 5.2)
Rating:48Neutral
Price Target:
kr0.61
▲(9.64% Upside)
The score is held back primarily by weak financial performance—continued losses and negative free cash flow despite a strong, low-leverage balance sheet. Technicals provide only modest support (price above short-term averages but below the 200DMA), while valuation is constrained by a negative P/E and no dividend yield provided.
Positive Factors
Very low leverage / strong solvency
Extremely low debt loads give the company durable financial flexibility, allowing it to absorb shortfalls, fund targeted investments or R&D, and survive operational volatility while pursuing a path to profitability without heavy interest burdens.
High gross margins
A ~73% gross margin indicates attractive unit economics for nasal products; structurally this supports reinvestment in distribution or marketing and provides room to cover fixed costs, improving the odds of achieving sustainable profits as scale grows.
Improving profitability trend
Narrowing losses versus prior years show management is making progress on cost control or product mix, which is a durable indicator that the business model can move toward breakeven if revenue stabilizes and efficiency gains continue.
Negative Factors
Negative operating and free cash flow
Persistent negative operating and free cash flow means the company requires external financing to fund ongoing operations and growth; this dependence constrains strategic choices, increases dilution or refinancing risk, and weakens long-term resilience.
Meaningful net losses
A deep negative net margin and negative returns indicate the capital base isn't producing profits; absent sustained revenue scaling or sharper cost reductions, this structural unprofitability threatens long-term viability and investor patience.
TTM revenue decline
Trailing-twelve-month revenue contraction suggests demand or distribution challenges; for a consumable-driven medical device business, declining top line undermines the ability to leverage high gross margins and threatens the path to sustainable cash generation.

Nosa Plugs AB (NOSA) vs. iShares MSCI Sweden ETF (EWD)

Nosa Plugs AB Business Overview & Revenue Model

Company DescriptionNosa Plugs AB, a medical technology company, manufactures and sells intranasal breathing products primarily in Europe and North America. Its products include NOSA plugs, such as NOSA odor control products for odor protection; NOSA microbial control products to reduce the exposure of viruses and bacteria by inhalation through the nose; and NOSA allergy filter that filters harmful airborne particles, such as pollen, pet dander, dust, and mold. The company was incorporated in 2014 and is based in Stockholm, Sweden.
How the Company Makes MoneyNosa Plugs AB generates revenue primarily through the sale of its electrical connectors and plugs, which are sold to various sectors, including automotive manufacturers, telecommunications companies, and electronics manufacturers. The company's revenue model is based on both direct sales to customers and partnerships with distributors who help reach a broader market. Key revenue streams include bulk orders from OEMs, smaller orders from retail clients, and custom connector solutions tailored to specific customer requirements. Additionally, NOSA has established significant partnerships with industry players, enabling collaborative product development and access to new markets, which further enhances its earning potential.

Nosa Plugs AB Financial Statement Overview

Summary
Balance sheet strength (very low leverage; Balance Sheet Score 72) is offset by weak operating fundamentals: revenue is down TTM (-3.7%) with continued large losses (Income Statement Score 34) and ongoing cash burn (Cash Flow Score 28). Profitability has improved versus prior years, but the business remains meaningfully unprofitable and not yet self-funding.
Income Statement
34
Negative
TTM (Trailing-Twelve-Months) revenue is down (-3.7%), but profitability has improved versus prior years: gross margin is strong (about 73%) and losses have narrowed materially from the very large 2023 and 2022 deficits. That said, the company remains meaningfully unprofitable with negative operating profit and a net loss (net margin around -54%), so the current earnings profile still relies on continued scaling and/or cost control to reach breakeven.
Balance Sheet
72
Positive
The balance sheet is a clear strength: leverage is very low in TTM (Trailing-Twelve-Months) with debt-to-equity near 0.01, and equity is sizable relative to the asset base. However, returns remain negative (TTM return on equity is meaningfully below zero), reflecting that the capital base is not yet producing positive earnings—good solvency, but weak profitability on capital.
Cash Flow
28
Negative
Cash generation remains pressured: TTM (Trailing-Twelve-Months) operating cash flow is negative and free cash flow is also negative, indicating ongoing cash burn. Free cash flow burn has improved versus 2024, but it is still not self-funding, and cash flow continues to lag net losses (i.e., the business has not yet converted operations into sustainable cash generation).
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue17.53M16.10M10.39M6.85M5.85M1.37M
Gross Profit12.79M11.20M6.92M-13.64M-6.45M-103.59M
EBITDA-6.99M-8.45M-44.98M-7.59M-38.60M-204.69M
Net Income-9.53M-10.16M-46.55M-17.82M-58.56M-229.12M
Balance Sheet
Total Assets67.06M20.70M33.08M21.67M40.09M116.25M
Cash, Cash Equivalents and Short-Term Investments18.82M4.31M1.19M2.52M10.40M87.81M
Total Debt305.00K1.01M1.88M1.72M9.04M3.28M
Total Liabilities25.36M4.14M6.33M3.33M980.00K14.61M
Stockholders Equity41.71M16.56M26.75M6.70M39.10M101.64M
Cash Flow
Free Cash Flow-3.42M-14.70M-18.35M-5.19M-16.81M-79.14M
Operating Cash Flow-8.04M-10.03M-17.50M-5.13M-6.21M-69.96M
Investing Cash Flow-14.39M-4.71M14.55M-61.00K-52.20M-8.21M
Financing Cash Flow31.31M17.81M1.61M5.29M-119.00K139.27M

Nosa Plugs AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.56
Price Trends
50DMA
0.54
Positive
100DMA
0.61
Negative
200DMA
0.70
Negative
Market Momentum
MACD
0.01
Negative
RSI
57.22
Neutral
STOCH
59.42
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOSA, the sentiment is Positive. The current price of 0.56 is above the 20-day moving average (MA) of 0.54, above the 50-day MA of 0.54, and below the 200-day MA of 0.70, indicating a neutral trend. The MACD of 0.01 indicates Negative momentum. The RSI at 57.22 is Neutral, neither overbought nor oversold. The STOCH value of 59.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NOSA.

Nosa Plugs AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
kr103.88M22.65
55
Neutral
$13.29B17.4210.03%0.93%7.13%-12.93%
48
Neutral
kr156.10M-14.5317.24%35.77%
48
Neutral
kr148.66M-3.13-27.22%16.38%35.71%
45
Neutral
kr66.10M-5.74
44
Neutral
kr207.09M-0.97-253.54%36.15%26.67%
44
Neutral
kr64.68M-3.02-60.20%163.12%30.50%
* Services Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:NOSA
Nosa Plugs AB
0.60
-0.38
-38.46%
SE:SCIB
SciBase Holding AB
0.25
-0.08
-24.92%
SE:LXB
Luxbright AB
0.50
-0.28
-36.28%
SE:BRAIN
BrainCool AB
0.44
-0.91
-67.29%
SE:ARCOMA
Arcoma AB
7.26
-3.74
-34.00%
SE:NEOLA
Neola Medical AB
0.85
-1.63
-65.81%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 30, 2026